Mega Genomics: The independent investigation firm did not identify any evidence of fraud or other misconduct by management

Mega Genomics (06667.HK) announced that regarding the resumption guidance received from the Stock Exchange on May 23 this year, the company must conduct appropriate independent forensic investigations on various audit issues, assess the impact on the company's business operations and financial condition, disclose the investigation results, and take appropriate remedial actions. The company has established an investigation committee and initiated an independent investigation.

The company pointed out that the investigation committee and the board of directors have reviewed the investigation report. After appropriate consideration, the investigation committee believes that the content and results of the investigation report are reasonable and acceptable. The investigation committee has recommended that the board adopt the results of the independent forensic investigation. Based on the forensic investigation procedures executed by the independent investigation company and the evidence currently obtained, the independent investigation company did not identify any evidence of fraud or other misconduct by management. The issues identified by the independent investigation company mainly pertain to the execution of internal controls and processes, and rectification has already been initiated.

The company believes that despite the aforementioned limitations, the content and results of the investigation report are reasonable and acceptable, and it has resolved to adopt the results of the investigation report. According to the findings of the independent investigation agency and the current evidence, the integrity, capability, and/or character of the current management team and/or individuals with significant influence over the company's current management and operations do not pose a risk to investors and will not undermine market confidence. The company is working with external independent consultants to prepare an internal control report and will disclose the results of the internal control report as soon as practicable, where feasible. The group's operations and business activities remain normal, and adjustments have been made to the revenue for the previous year.

At the company's request, trading of its shares has been suspended on the Stock Exchange since 9:00 AM on April 1 of this year and will continue to be suspended until further notice